ReviewDiabetologia2024
Use of diabetes technology in children.
Review in Diabetologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Diabetes technology (Update 2026)].Wiener klinische Wochenschrift · 2026Guideline
- Artificial Intelligence-Driven Digital Tools for Diabetes Self-management in Children: A Scoping Review.International journal of endocrinology and metabolism · 2027Review
- Diabetes Technology in the School Setting for Preschool-Aged Children.Journal of diabetes science and technology · 2026Article
- Artificial intelligence in pediatric diabetes: clinical benefits, developmental risks, and ethical challenges.European journal of pediatrics · 2026Review
- Mind-glucose control interplay in type 1 diabetes: management of exam-related stress using the MiniMed™ 780G insulin pump among high school students.Diabetology & metabolic syndrome · 2026Article
- Secular trends in HbA1c levels among children and adolescents with type 1 diabetes.Frontiers in endocrinology · 2026Article
- Teplizumab for stage 2 type 1 diabetes: a new era in pediatric diabetes prevention.European journal of pediatrics · 2025Review
- Association between caregiver health literacy and patient characteristics in pediatric new onset diabetes mellitus.Public health · 2025Article
- Algorithm-Driven Initiation and Adaptation of Hybrid Closed-Loop in Young Children with Type 1 Diabetes: A Pilot Study.Diabetes technology & therapeutics · 2025Article
- Impact of Socioeconomic Deprivation on Access to Diabetes Technology in Children With Type 1 Diabetes Mellitus.Cureus · 2025Article
- Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system.Diabetes, obesity & metabolism · 2025Article
- A Multidisciplinary Approach of Type 1 Diabetes: The Intersection of Technology, Immunotherapy, and Personalized Medicine.Journal of clinical medicine · 2025Review
- The Rise and Rise of Type 1 and Type 2 Diabetes in Youth.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Review
- Burden of Treatment in Children and Adolescents With Type 1 Diabetes Evaluated by Focus Groups.Pediatric diabetes · 2025Article
- The future is here: an overview of technology in diabetes.Diabetologia · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Children with type 1 diabetes and their caregivers face numerous challenges navigating the unpredictability of this complex disease. Although the burden of managing diabetes remains significant, new technology has eased some of the load and allowed children with type 1 diabetes to achieve tighter glycaemic management without fear of excess hypoglycaemia. Continuous glucose monitor use alone improves outcomes and is considered standard of care for paediatric type 1 diabetes management. Similarly, automated insulin delivery (AID) systems have proven to be safe and effective for children as young as 2 years of age. AID use improves not only blood glucose levels but also quality of life for children with type 1 diabetes and their caregivers and should be strongly considered for all youth with type 1 diabetes if available and affordable. Here, we review key data on the use of diabetes technology in the paediatric population and discuss management issues unique to children and adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.